| Chen, Jian |
NCT03521986: Pain and Quality of Life After Mediastinal Tumor Resection by Subxiphoid and Intercostal VATS |
|
|
| Recruiting | 3 | 100 | RoW | Subxiphoid uniportal VATS, Intercostal uniportal VATS | Lei Jiang | Mediastinal Neoplasms, Thoracic Neoplasm, Thoracic Surgery | 10/23 | 10/23 | | |
NCT03523468: Curative Effect and Quality of Life Between Uniportal and Open Sleeve Lobectomy for Central Type Lung Cancer |
|
|
| Recruiting | 3 | 200 | RoW | uniportal sleeve lobectomy, open sleeve lobectomy | Lei Jiang, Shanghai Pulmonary Hospital, Shanghai, China | Video-Assisted Thoracic Surgery, Lung Cancer | 05/24 | 12/24 | | |
NCT06205927: Randomized Study of Carbon Ion Boost in Hypoxic Lesions for Locally Advanced Non-small Cell Lung Cancer |
|
|
| Recruiting | 2 | 77 | RoW | Standard carbon ion beam radiotherapy, Carbon ion beam radiotherapy simultaneously dose boost | Jian Chen | Non-small Cell Lung Cancer | 12/24 | 12/26 | | |
NCT06186726: Clinical Study of Carbon Ion Radiotherapy Combined With Chemotherapy for Thymic Epithelial Tumors |
|
|
| Recruiting | 2 | 48 | RoW | carbon ion radiotherapy | Jian Chen | Carbon Ion Radiotherapy, Thymoma, Thymic Carcinoma, Radiotherapy, Chemotherapy | 12/26 | 12/29 | | |
NCT06311981: Carbon Ion Radiotherapy for Locally Advanced Lung Cancer in Elderly Patients |
|
|
| Recruiting | 2 | 29 | RoW | carbon ion radiotherapy, targeted therapy, single regimen chemotherapy in sequence with radiotherapy | Jian Chen | Non-small Cell Lung Cancer, Older People, Carbon Ion Radiotherapy, Radiotherapy Side Effect | 06/25 | 06/26 | | |
NCT06311955: Clinical Study of Postoperative Carbon Ion Radiotherapy for Thymus Tumor With Residual Tumor |
|
|
| Recruiting | 2 | 48 | RoW | Carbon ion radiotherapy, combined with platinum-based regimen | Jian Chen | Thymic Epithelial Tumor, Radiotherapy Side Effect, Carbon Ion Radiotheray, Heavy Ion Radiotherapy | 02/28 | 02/29 | | |
NCT06311968: The Clinical Study of Post-operative Proton Radiotherapy for Thymus Tumor |
|
|
| Recruiting | 2 | 55 | RoW | Proton radiotherapy, combined platinum based chemotherapy | Jian Chen | Thymus Epithelial Tumor, Proton Radiotherapy, Radiation Toxicity | 02/27 | 02/27 | | |
SPH5030-201, NCT06434597: A Clinical Study of SPH5030 Tablets in the Treatment of Her2-positive/Mutated Biliary Tract OR Colorectal Cancer Patients. |
|
|
| Recruiting | 2 | 60 | RoW | SPH5030 | Shanghai Pharmaceuticals Holding Co., Ltd | Biliary Tract or Colorectal Cancer With Her2-positive/Mutated | 12/26 | 12/26 | | |
NCT05613452: Carbon Ion Therapy for Peripheral Non-small Cell Lung Cancer |
|
|
| Recruiting | 2 | 43 | RoW | Carbon ion beam radiotherapy | Shanghai Proton and Heavy Ion Center | Non-small Cell Lung Cancer | 01/25 | 01/26 | | |
NCT05715931: Perioperative Chemotherapy Plus Trastuzumab Plus Toripalimab in HER2 Positive Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma |
|
|
| Recruiting | 2 | 30 | RoW | Toripalimab, Trastuzumab, 5-FU, leucovorin, docetaxel, oxaliplatin (FLOT) | Yu jiren | Adenocarcinoma of the Stomach, Adenocarcinoma of Esophagogastric Junction, HER2-positive Gastric Cancer | 03/25 | 03/28 | | |
NCT05729646: Perioperative Chemotherapy Plus Toripalimab for dMMR Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma |
|
|
| Recruiting | 2 | 90 | RoW | Toripalimab, Oxaliplatin, S1 | Yu jiren | Adenocarcinoma of the Stomach, Adenocarcinoma of Esophagogastric Junction, Mismatch Repair Deficiency | 02/26 | 02/29 | | |
NCT05872685: Perioperative Chemotherapy Combined With Serplulimab or Placebo for pMMR Locally Advanced Gastric Adenocarcinoma (FOCUS-05) |
|
|
| Recruiting | 2 | 314 | RoW | S1, Oxaliplatin, Serplulimab, Placebo | Yu jiren | Adenocarcinoma of the Stomach, Adenocarcinoma of Esophagogastric Junction, Proficient Mismatch Repair | 04/26 | 04/29 | | |
NCT05970627: Perioperative Chemotherapy Plus Toripalimab for Epstein-Barr Virus-associated Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma |
|
|
| Not yet recruiting | 2 | 30 | RoW | Toripalimab, Oxaliplatin, S1 | Yu jiren | Adenocarcinoma of the Stomach, Adenocarcinoma of Esophagogastric Junction, Epstein-Barr Virus-Associated Gastric Carcinoma | 07/26 | 07/29 | | |
NCT05688488: Clinical Study of Curcumin in Preventing Postoperative Adhesion of Bilateral Vocal Cords |
|
|
| Recruiting | 1/2 | 100 | RoW | Curcumin, Mitomycin-C | Eye & ENT Hospital of Fudan University | Glottic Web of Larynx, Laryngeal Stenosis, Glottic Carcinoma, Laryngeal Leucoplakia, Laryngeal Polyp, Laryngeal Papilloma | 12/25 | 12/26 | | |
| Recruiting | 1 | 150 | RoW | GQ1005 | GeneQuantum Healthcare (Suzhou) Co., Ltd. | HER2 Expressing or Mutated Advanced Malignant Solid Tumors | 12/24 | 07/25 | | |
NCT06614686: U87 CAR-T in Patients With Advanced Head and Neck Tumors |
|
|
| Recruiting | 1 | 20 | RoW | U87 autologous CAR T-cell | Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd | Nasopharynx Cancer, Head and Neck Cancer | 10/26 | 12/27 | | |
NCT05685719: A Study to Evaluate the Relative Bioavailability of STI-1558 and the Effect of Itraconazole and Rifampin on the Pharmacokinetics of STI-1558 |
|
|
| Completed | 1 | 37 | RoW | STI-1558, Itraconazole, Rifampin | Zhejiang ACEA Pharmaceutical Co. Ltd. | COVID-19 Pneumonia | 03/23 | 11/23 | | |
NCT05627063: A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK121-NX in Patients With Advanced Solid Tumors |
|
|
| Recruiting | 1 | 169 | US, RoW | ABSK121-NX | Abbisko Therapeutics Co, Ltd | Solid Tumor | 03/25 | 06/25 | | |
| Recruiting | 1 | 54 | RoW | HF1K16 /Arm 45 mg/m², HF1K16 /Arm 90 mg/m², HF1K16 /Arm 120 mg/m², HF1K16 /Arm 160 mg/m², HF1K16 /Arm 120 mg or 180 mg | HighField Biopharmaceuticals Corporation, Tigermed Consulting Co., Ltd | Solid Tumor, Adult | 04/25 | 11/25 | | |
NCT05861895: A Clinical Study to Investigate the Safety, Tolerability, Pharmacokinetics, Immunogenicity and Preliminary Efficacy of HF158K1 in Participants With HER-2 Positive or HER-2 Low Expression Advanced Solid Tumors |
|
|
| Recruiting | 1 | 84 | US | HF158K1 /Arm 2 mg/m², Infusion, HF158K1 /Arm 6 mg/m², HF158K1 /Arm 15 mg/m², HF158K1 /Arm 30 mg/m², HF158K1 /Arm 45 mg/m², HF158K1 /Arm 60 mg/m² | HighField Biopharmaceuticals Corporation | Solid Tumors, Adult | 04/25 | 12/25 | | |
NCT05827328: Explore the Optimal Surgical Timing for Lung Surgery and Mediastinal Surgery After COVID-19 Infection |
|
|
| Completed | N/A | 2000 | RoW | Observation | Shanghai Pulmonary Hospital, Shanghai, China | Thoracic Diseases, Thoracic Surgery | 06/23 | 06/23 | | |
NCT06340295: A Multicenter, Prospective Cohort Study of Preserved Ratio Impaired Spirometry(PRISm) in a Population |
|
|
| Recruiting | N/A | 2000 | RoW | | Peking University First Hospital, Shanxi Bethune Hospital, First Affiliated Hospital Xi'an Jiaotong University, Tianjin Medical University General Hospital, The First Hospital of Qinhuangdao, Shandong Provincial Hospital, Second Hospital of Jilin University, People's Hospital of Xinjiang Uygur Autonomous Region, MinDong Hospital of Ningde City | COPD | 05/26 | 05/26 | | |
| Recruiting | N/A | 150 | RoW | Consumer wearable device | Peking University First Hospital | COPD | 09/23 | 09/23 | | |
CHENJIAN1, NCT06126393: MRI Radiomics Combined With Pathomics on the Prediction of Molecular Classification and Prognosis of Endometrial Cancer |
|
|
| Not yet recruiting | N/A | 350 | RoW | next generation sequencing AND Immunohistochemical examination, Magnetic resonance examination | Fujian Cancer Hospital, Fujian Provincial Hospital, First Affiliated Hospital of Fujian Medical University, Gutian Hospital | Endometrial Neoplasms | 03/27 | 06/27 | | |
NCT06396143: Research on Intelligent Screening and Decision-making for Neoadjuvant Therapy in Locally Advanced Gastric Cancer Based on Multi-omics Integration |
|
|
| Recruiting | N/A | 120 | RoW | | Zhejiang University | Locally Advanced Gastric Carcinoma | 06/25 | 12/25 | | |
NCT06551675: Effect of Silkworm Pupa Tablets in Gastrointestinal Malignancies at Nutritional Risk Following Radical Surgery |
|
|
| Recruiting | N/A | 120 | RoW | Silkworm pupa tablets, Control product | Xiaosun Liu, MD | Nutritional Deficiency, Gastrointestinal Cancer, Frailty Syndrome | 11/25 | 11/25 | | |
NCT06140589: Exploring the Efficacy, Safety and Cost-effectiveness Analysis of Cadonilimab in the Treatment of Cervical Cancer |
|
|
| Recruiting | N/A | 200 | RoW | Cadonilimab | Fujian Cancer Hospital, Fujian Medical University Affiliated Nanping First Hospital, The First Hospital Affiliated to Fujian Medical University, Fujian Medical University Union Hospital, Gutian Hospital, Jiangxi Provincial Cancer Hospital, Shunde Women and Children's Hospital (Maternity and Child Healthcare Hospital of Shunde Foshan), Lianyungang Donghai County People's Hospital, Changsha Maternal and Child Health Hospital, Pingxiang Maternal and Child Health Hospital, Huinan County People's Hospital, People's Hospital Affiliated to Fujian University of Traditional Chinese Medicine | Cervical Cancer | 12/24 | 12/26 | | |
NCT04212494: Thrombus Aspiration in STEMI Patients With High Thrombus Burden |
|
|
| Recruiting | N/A | 3838 | RoW | Thrombus aspiration, PCI Alone | Guangdong Provincial People's Hospital, Zhongshan People's Hospital, Guangdong, China, Kaiping Central Hospital, The Second Affiliated Hospital of Shantou University Medical College, The Third Xiangya Hospital of Central South University, Sihui City People's Hospital, Shenzhen Baoan District Shiyan People's Hospital, People's Hospital of Nanxiong County, Yuebei People's Hospital, Weifang Medical University, Wuzhou Gongren Hospital, Dafeng Hospital of Chaoyang District in Shantou City, Shenzhen Baoan People's Hospital, Dongguan People's Hospital, Yangchun People's Hospital, Taishan People's Hospital, The Second People's Hospital of Foshan, Guangzhou Hospital of integrated Traditional and West Medicine, Guangning People's Hospital, Foshan Sanshui District People's Hospital, Qingyuan People's Hospital, Luhe County People's Hospital, People's Hospital of Xinjiang Uygur Autonomous Region, The Fourth People's Hospital of Chenzhou, People's Hospital of Dapu County, Shenzhen People's Hospital, Heyuan people's Hospital, Huaiji People's Hospital, People's Hospital of Yingde City, Qingyuan Hospital of Traditional Chinese Medicine Affiliated To Guangzhou University of Traditional Chinese Medicine, Zhongshan Hospital Of Traditional Chinese Medicine, The Third Affiliated Hospital of Guangzhou Medical University, Lianzhou People's Hospital, Lianping Xian Ren Ming Yi Yuan, Guangxi Zhuang Autonomous Region Nationalities Hospital, Liuzhou Municipal Liutie Central Hospital, Chen Zhou 3RD People's Hospital, Longgang District Central Hospital of Shenzhen, The Affiliated Shunde Hospital of Jinan University, Shenzhen Longhua District Central Hospital, Shantou Central Hospital, Tongxiang First People's Hospital, Bobai County People's Hospital, Guangxi, Meizhou Traditional Chinese Medicine Hospital, The Third Affiliated Hospital of Sun Yat-Sen University, Yuedong Hospital, Shenzhen Third People's Hospital, Yangjiang People's Hospital, Jiangmen Central Hospital, Eighth Affiliated Hospital, Sun Yat-sen University, The First People's Hospital of Kashgar Erea, First People's Hospital of Foshan, Zhaoqing Gaoyao People's Hospital, People's Hospital of Nanhai District, Foshan, The Second Affiliated Hospital of Dalian Medical University, Nanning Second People's Hospital, The Second People's Hospital of Nanhai District of Foshan, Shangyou People's Hospital | ST-segment Elevation Myocardial Infarction (STEMI) | 08/25 | 02/26 | | |
NCT04912401: the Efficacy and Safety of Etanercept （Yi Sai Pu) in Chinese Patients With Moderate-to-Severe Psoriasis |
|
|
| Recruiting | N/A | 100 | RoW | | Second Affiliated Hospital, School of Medicine, Zhejiang University | Psoriasis, Etanercept | 12/25 | 12/25 | | |
NCT04995159: Optimized Antiplatelet Therapy in Patients With CHD After Implantation of NeoVasâ„¢ BRS System |
|
|
| Not yet recruiting | N/A | 2150 | RoW | Single anti-platelet therapy, SAPT strategy, Dual anti-platelet therapy, DAPT strategy | Lepu Medical Technology (Beijing) Co., Ltd. | Coronary Heart Disease | 01/26 | 01/28 | | |
REPAIR PERS-AF, NCT06098989: A Prospective Study of REPeat Ablation In Patients With Recurrent PERSistent Atrial Fibrillation: Pulmonary Vein Isolation vs. Adjunct Posterior Wall Isolation ( Study) |
|
|
| Not yet recruiting | N/A | 150 | NA | Radio frequency ablation | Haukeland University Hospital, St. Olavs Hospital, University Hospital of North Norway | Atrial Fibrillation, Persistent, Atrial Fibrillation Recurrent | 11/26 | 11/26 | | |
NCT05540821: Efficacy of Double Contrast-enhanced Ultrasound of Pelvic in Preoperative Evaluation of Deep Endometriosis |
|
|
| Recruiting | N/A | 156 | RoW | Hysterosalpingo-contrast sonography and sonoPODography | Shenzhen Second People's Hospital | Deep Endometriosis | 06/25 | 06/25 | | |
NCT05697926: Preclinical Research for Personalized TCR-T Therapy for Head and Neck Cancer |
|
|
| Recruiting | N/A | 100 | RoW | No intervention | Eye & ENT Hospital of Fudan University | Head and Neck Cancer | 12/25 | 06/26 | | |
| ma, jun |
NCT05353205: A Study of the Efficacy and Safety of Flumatinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase. |
|
|
| Recruiting | 4 | 200 | RoW | Flumatinib mesylate tablets (400mg), Flumatinib mesylate tablets (600mg) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | CML, Chronic Phase | 12/22 | 09/25 | | |
NCT06343935: A National Multicenter, Real-world Study of Linperlisib in the Treatment of Lymphoma |
|
|
| Not yet recruiting | 4 | 88 | NA | Linperlisib, YY-20394 | Shanghai YingLi Pharmaceutical Co. Ltd. | Indolent B-cell Lymphoma | 04/24 | 04/25 | | |
NCT05367765: A Real World Study of the Efficacy and Safety of Flumatinib Versus Imatinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase |
|
|
| Not yet recruiting | 4 | 2400 | RoW | Flumatinib, Imatinib | Jiangsu Hansoh Pharmaceutical Co., Ltd. | CML, Chronic Phase | 04/27 | 04/28 | | |
CONTINUUM, NCT03700476: Sintilimab (PD-1 Antibody) and Chemoradiotherapy in Locoregionally-advanced Nasopharyngeal Carcinoma |
|
|
| Active, not recruiting | 3 | 425 | RoW | Sintilimab, IBI308, PD-1 antibody, Gemcitabine, Cisplatin, DDP, intensity-modulated radiotherapy, IMRT | Sun Yat-sen University, Innovent Biologics (Suzhou) Co. Ltd. | Nasopharyngeal Neoplasms | 02/23 | 01/25 | | |
DIPPER, NCT03427827: PD-1 Antibody Versus Best Supportive Care After Chemoradiation in Locoregionally Advanced Nasopharyngeal Carcinoma |
|
|
| Active, not recruiting | 3 | 450 | RoW | Camrelizumab, SHR-1210 | Sun Yat-sen University | Nasopharyngeal Neoplasms | 02/24 | 02/26 | | |
NCT06239727: Reduced-dose Radiotherapy for Stage III Nasopharyngeal Carcinoma Based on the Treatment Response |
|
|
| Recruiting | 3 | 593 | RoW | PD-1 blocking antibody, Camrelizumab, Gemcitabine, GEM, Cisplatin (80 mg/m2), DDP, Reduced-dose Intensity-modulated radiotherapy, Reduced-dose IMRT, Conventional-dose Intensity-modulated radiotherapy, Conventional-dose IMRT, Cisplatin (100 mg/m2), Capecitabine | Sun Yat-sen University, Jiangsu Hengrui Pharmaceutical Co., Ltd. | Nasopharyngeal Carcinoma | 02/27 | 02/30 | | |
NCT06434467: The Efficacy and Safety of Nelarabine Injection in Patients With T-lymphoblastic Leukemia and T-lymphoblastic Lymphoma |
|
|
| Not yet recruiting | 3 | 83 | RoW | Nelarabine injection | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | T-lymphoblastic Leukemia, T-lymphoblastic Lymphoma | 12/25 | 05/26 | | |
NCT06514508: Mobilization of Stem Cells With Motixafortide (BL-8040) in Combination With G-CSF in Multiple Myeloma Patients |
|
|
| Not yet recruiting | 3 | 60 | RoW | Motixafortide+G-CSF, BL-8040+G-CSF, Placebo+G-CSF | Guangzhou Gloria Biosciences Co., Ltd. | Multiple Myeloma | 08/26 | 12/26 | | |
NCT06749899: QL1706 (IPD-1/CTLA-4 Bi-specific Antibody) and Chemoradiotherapy in Locoregionally-advanced Nasopharyngeal Carcinoma. |
|
|
| Recruiting | 3 | 580 | RoW | QL1706, Gemcitabine, Cisplatin, Intensity-modulated radiotherapy | Sun Yat-sen University, Qilu Pharmaceutical Co., Ltd. | Nasopharyngeal Cancinoma (NPC), Nasopharyngeal Cancer | 12/28 | 12/30 | | |
AK104-IIT-019, NCT05587374: Cadonilimab (PD-1/CTLA-4 Bi-specific Antibody) and Chemoradiotherapy in Locoregionally-advanced Nasopharyngeal Carcinoma |
|
|
| Recruiting | 3 | 418 | RoW | Cadonilimab, PD-1/CTLA-4 bi-specific antibody, Gemcitabine, GEM, Cisplatin, DDP, Intensity-modulated radiotherapy, IMRT | Sun Yat-sen University, Akeso Pharmaceuticals, Inc. | Nasopharyngeal Carcinoma, Nasopharyngeal Cancer | 01/25 | 01/27 | | |
DIAMOND, NCT04907370: PD-1 Blockade Combined With De-intensification Radical Chemoradiotherapy in Nasopharyngeal Carcinoma |
|
|
| Active, not recruiting | 3 | 540 | RoW | PD-1 blocking antibody, PD-1 Blockade, Gemcitabine, GEM, Cisplatin (80mg/m2), DDP, Cisplatin (100mg/m2), Intensity-modulated radiotherapy, IMRT | Sun Yat-sen University, Shanghai Junshi Bioscience Co., Ltd. | Nasopharyngeal Carcinoma | 05/25 | 05/27 | | |
DESTINY, NCT05334368: Depemokimab in Participants With Hypereosinophilic Syndrome, Efficacy, and Safety Trial |
|
|
| Recruiting | 3 | 120 | Europe, Canada, Japan, US, RoW | Depemokimab, Placebo | GlaxoSmithKline | Hypereosinophilic Syndrome | 02/26 | 03/26 | | |
NCT05342792: Metronomic Capecitabine With or Without PD-1 Antibody as Adjuvant Therapy in High-risk Nasopharyngeal Carcinoma |
|
|
| Recruiting | 3 | 556 | RoW | PD-1 antibody, Tislelizumab, Capecitabine | Sun Yat-sen University, Tongji Hospital, Wuhan Union Hospital, China, Xiangya Hospital of Central South University, Affiliated Cancer Hospital of Guizhou Medical University, Cancer Hospital of Guangxi Medical University, First People's Hospital of Foshan, Chongqing University Cancer Hospital, Hubei Cancer Hospital, Hunan Cancer Hospital, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, Fifth Affiliated Hospital, Sun Yat-Sen University, Shandong Provincial Hospital | Nasopharyngeal Carcinoma | 06/27 | 06/29 | | |
ALOHA, NCT05251402: Addressing Quality of Life, Clinical Outcomes, and Mechanisms in Uncontrolled Asthma Following the DASH Dietary Pattern |
|
|
| Recruiting | 2/3 | 320 | US | Group A - Patient Education, Group B - Patient Education with Nutrition Counseling | University of Illinois at Chicago, Stanford University, University of Vermont, University of Newcastle, Australia, National Heart, Lung, and Blood Institute (NHLBI), University of Chicago | Asthma | 06/26 | 09/26 | | |
NCT03619824: PD-1 Blockade Combined With Definitive Chemoradiation in Locoregionally-advanced Nasopharyngeal Carcinoma |
|
|
| Not yet recruiting | 2 | 40 | RoW | Sintilimab, IBI308, PD-1 antibody, Gemcitabine, Cisplatin, DDP, intensity-modulated radiotherapy, IMRT | Sun Yat-sen University, Innovent Biologics (Suzhou) Co. Ltd. | Nasopharyngeal Neoplasms | 10/19 | 03/24 | | |
TQB2618-AK105-II-01, NCT05563480: TQB2618 Injection Combined With Penpulimab Injection in the Treatment of Patients With Recurrent/Metastatic Nasopharyngeal Carcinoma |
|
|
| Recruiting | 2 | 90 | RoW | TQB2618 Injection, Pempulimab Injection, Cisplatin Injection, Gemcitabine Hydrochloride Injection, Penpulimab injection, Cisplatin Injection, Gemcitabine Hydrochloride Injection, TQB2618 injection; Penpulimab injection | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Nasopharyngeal Carcinoma | 10/23 | 05/24 | | |
PLATINUM, NCT03984357: Nivolumab Combined With Chemoradiotherapy Sparing Concurrent Cisplatin in Nasopharyngeal Carcinoma |
|
|
| Active, not recruiting | 2 | 152 | RoW | PD-1 blocking antibody, PD-1 blockade, Gemcitabine, GEM, Cisplatin, DDP, Intensity-modulated radiotherapy, IMRT | Sun Yat-sen University, Bristol-Myers Squibb | Nasopharyngeal Carcinoma | 04/24 | 03/26 | | |
NCT05716087: A Study of Rocbrutinib in Participants with Relapse or Refractory Mantle Cell Lymphoma |
|
|
| Active, not recruiting | 2 | 62 | RoW | Rocbrutinib, NWP-775, LP-168 | Guangzhou Lupeng Pharmaceutical Company LTD. | Mantle Cell Lymphoma (MCL) | 12/24 | 12/25 | | |
| Recruiting | 2 | 25 | RoW | STSP-0601 for Injection | Staidson (Beijing) Biopharmaceuticals Co., Ltd | Hemophilia | 02/25 | 02/25 | | |
| Recruiting | 2 | 50 | RoW | Adebrelimab | Sun Yat-sen University, Nanfang Hospital, Southern Medical University, West China Hospital, The First Affiliated Hospital of Xiamen University | Nasopharyngeal Carcinoma, Nasopharyngeal Cancer | 05/28 | 05/28 | | |
| Not yet recruiting | 2 | 110 | NA | The combination treatment of anlotinib, penpulimab and capecitabine. | Sun Yat-sen University, Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Nasopharyngeal Neoplasms | 10/24 | 10/25 | | |
NCT06092606: A Multicenter Clinical Trial on DH001 Tablets in the Prevention of Doxorubicin-induced Cardiotoxicity in Cancer Patients |
|
|
| Recruiting | 2 | 90 | RoW | Control group:DH001 placebo, Control group, Trial group: DH001 low-dose group, Trial group: DH001 high-dose group | Monyan Pharmaceutical (Shanghai) Co., Ltd. | Cancer, Heart Failure, Arrhythmia, Doxorubicin Induced Cardiomyopathy, Doxorubicin Adverse Reaction | 01/25 | 01/25 | | |
ACE-D, NCT06408246: Accelerating Cognition-guided Signatures to Enhance Translation in Depression: Clinical Trial |
|
|
| Not yet recruiting | 2 | 160 | US | Guanfacine, Sertraline | Stanford University | Depression | 10/28 | 02/29 | | |
NCT05155839: Safety and Preliminary Efficacy Study of MRG001 in Patients With Non-Hodgkin Lymphoma (NHL) |
|
|
| Recruiting | 1 | 108 | RoW | MRG001 | Shanghai Miracogen Inc. | Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (NHL) | 10/22 | 10/23 | | |
NCT04991129: The Safety and Efficacy of Multiple-dose of WJ01024 in Subject With Advanced Cancer |
|
|
| Recruiting | 1 | 66 | RoW | WJ01024 | Suzhou Junjing BioSciences Co., Ltd. | Advanced Hematologic Malignancies, Advanced Solid Tumors | 06/25 | 04/26 | | |
NCT03048305: Prospective Study for Molecular Biomarkers of Normal Nasopharyngeal Tissue |
|
|
| Recruiting | N/A | 200 | RoW | | Sun Yat-sen University, Guilin Medical University, China, First People's Hospital of Foshan | Nasopharyngeal Carcinoma | 12/20 | 01/23 | | |
NCT03346109: To Study the Feasibility and Quality of Life of Medial Group Retropharyngeal Node Sparing in Nasopharyngeal Carcinoma |
|
|
| Active, not recruiting | N/A | 568 | RoW | medial group retropharyngeal node（MRLN） sparing | Sun Yat-sen University | Nasopharyngeal Carcinoma | 12/21 | 12/22 | | |
NCT03366597: The Research of the Effect of Sevoflurane on Brain-protection of Cardiac Surgery in Infants. |
|
|
| Recruiting | N/A | 100 | RoW | Sevoflurane | Jun Ma | Congenital Heart Disease, Infant, Premature, Diseases | 12/21 | 12/22 | | |
NCT04511182: Early Individualized-Exercise Based Cardiac Rehabilitation Programs in Patients With Acute Myocardial Infarction |
|
|
| Not yet recruiting | N/A | 160 | RoW | Exercise-based cardiac rehabilitation | RenJi Hospital | Acute Myocardial Infarction | 08/22 | 02/23 | | |
NCT03025854: Prospective Study for Prognostic Biomarkers of Nasopharyngeal Carcinoma |
|
|
| Recruiting | N/A | 600 | RoW | | Sun Yat-sen University, Guilin Medical University, China, First People's Hospital of Foshan | Nasopharyngeal Carcinoma | 12/22 | 01/23 | | |
NCT05055570: Angiotensin II Pathway and Postoperative Hypoxemia |
|
|
| Completed | N/A | 88 | RoW | No intervention | Beijing Anzhen Hospital | Aortic Dissection | 06/22 | 06/22 | | |
NCT06552143: An Applied Study on the Use of Stone Needles Therapy to Assist the Rehabilitation of Maternal Diastasis Rectus Abdominis Based on the Theory of Belt Channel |
|
|
| Recruiting | N/A | 120 | RoW | Stone needle therapy follows the Belt channel | Yunnan University of Chinese Medicine | Diastasis Recti Abdominis | 09/24 | 09/24 | | |
NCT05606510: The Effects of Mindful Exercise on Back Pain in Older Patients With Primary Osteoporosis |
|
|
| Recruiting | N/A | 128 | RoW | Mindful exercise, usual care | University of Malaya | Older People, Primary Osteoporosis, Back Pain | 10/23 | 04/24 | | |
SPEAC, NCT05603923: Study of a PST-Trained Voice-Enabled Artificial Intelligence Counselor() for Adults With Emotional Distress (Phase 2) |
|
|
| Active, not recruiting | N/A | 200 | US | Lumen Coached PST Intervention., Human Coached PST Intervention., Optional (delayed) Lumen Coached PST (Waitlist control). | University of Illinois at Chicago, Penn State University, Washington University School of Medicine, Stanford University, National Institute of Mental Health (NIMH) | Depression, Anxiety | 05/25 | 07/25 | | |
NPC-LN, NCT05389306: Combining MRI and CEUS to Diagnose Small Cervical Lymph Node Metastases in NPC Patients |
|
|
| Recruiting | N/A | 348 | RoW | MRI Scanning, Contrast-Enhanced Ultrasonography, Ultrasound-guided Lymph Node Aspiration | Sun Yat-sen University | Nasopharyngeal Carcinoma | 12/24 | 12/24 | | |
IGNITE, NCT06636058: Digital InteGrated Behavioral TreatmeNt for Comorbid ObesITy and DeprEssion Among Racial and Ethnic Adults Age 50 and Older |
|
|
| Not yet recruiting | N/A | 440 | US | vCare Intervention (6-month active treatment followed by 6-month maintenance), vCare Intervention (active treatment after 6 months) | University of Illinois at Chicago, Washington University School of Medicine, National Institute on Aging (NIA) | Obesity, Depression | 04/28 | 10/28 | | |
PIVOT, NCT05654142: The Trial: Project on EHR-Integrated Lifestyle Interventions for Adults Aged Fifty and Older |
|
|
| Recruiting | N/A | 1029 | US | Base intervention, Augmented Intervention | University of Illinois at Chicago, Washington University School of Medicine, University of Pittsburgh | CARDIOMETABOLIC CONDITIONS, Obesity, Pre-diabetes, Metabolic Syndrome, Type2diabetes, Hypertension, Dyslipidemias | 10/26 | 10/26 | | |
ABC care, NCT06060470: Active Balance and Cardio Care Intervention on Physical and Cardiovascular Health in People With Chronic Stroke |
|
|
| Not yet recruiting | N/A | 120 | US | Virtual reality based dance group, Active Balance Cardio (ABC) care, Active Comparator: Control, Control | University of Illinois at Chicago | Chronic Stroke | 10/28 | 10/28 | | |
NCT05211934: Relationship Between Postoperative Delirium and Heart Function in Valvular Surgery |
|
|
| Recruiting | N/A | 300 | RoW | No intervention | Beijing Anzhen Hospital | Valvular Surgery | 07/24 | 07/24 | | |
| Ji, Mingfang |
| Active, not recruiting | N/A | 87600 | RoW | Experimental: Screening with EBV VCA/EBNA1-IgA testing, Diagnostic work-up using fiberoptic endoscopy examination and/or nasopharyngeal biopsies | Sun Yat-sen University, Cancer Research Institute of Zhongshan City, Sihui Cancer Institute | Nasopharyngeal Cancer, Screening, Morality | 12/19 | 12/23 | | |
NCT02501993: Nasopharyngeal Carcinoma Screening in Zhongshan City |
|
|
| Active, not recruiting | N/A | 25000 | RoW | | Zhongshan People's Hospital, Guangdong, China | Nasopharyngeal Carcinoma | 12/19 | 12/23 | | |
NCT02501980: Hepatocellular Cancer (HCC) Screening in Zhongshan City |
|
|
| Active, not recruiting | N/A | 20000 | RoW | Biomarker testing and Ultrasonography | Zhongshan People's Hospital, Guangdong, China | Liver Neoplasms | 01/24 | 12/24 | | |
NCT04085900: Screening Nasopharyngeal Carcinoma With EBV Associated Biomarkers in Zhongshan City |
|
|
| Recruiting | N/A | 40000 | RoW | Blood and saliva, P85-Ab, EBNA1-IgA, VCA-IgA and EBV DNA, Fiberoptic endoscopy and biopsy | Zhongshan People's Hospital, Guangdong, China, Wuzhou Red Cross Hospital, Xiamen University | Nasopharyngeal Carcinoma | 12/24 | 12/27 | | |
| Mai, Haiqiang |
| Active, not recruiting | 3 | 450 | RoW | Tislelizumab, BGB-A317, Placebo | Sun Yat-sen University, Cancer Hospital of Guizhou Province, Hunan Cancer Hospital, Wuzhou Red Cross Hospital, Affiliated Hospital of Guangdong Medical University | Nasopharyngeal Carcinoma | 05/26 | 05/28 | | |
NCT03020329: Induction Chemotherapy in Young Patients With Locoregionally Advanced Nasopharyngeal Carcinoma |
|
|
| Recruiting | 2 | 37 | RoW | Paclitaxel liposome, Paclitaxel liposome,cisplatin,fluorouracil(TPF) chemotherapy, Cisplatin, TPF induction chemotherapy, Concurrent cisplatin, 5-fu, Radical radiotherapy, Concurrent radiotherapy | Sun Yat-sen University | Nasopharyngeal Carcinoma, Children | 12/20 | 12/22 | | |
NCT04223024: Concurrent Chemoradiotherapy With Nimotuzumab for High Risk Nasopharyngeal Carcinoma |
|
|
| Active, not recruiting | 2 | 246 | RoW | CCRT+Nimotuzumab, Nimotuzumab, CCRT alone | Sun Yat-sen University | Nasopharyngeal Carcinoma | 12/22 | 12/26 | | |
NCT05913414: Iron Isomaltide for Iron-deficiency Anemia Patients With Locally Advanced Nasopharyngeal Carcinoma |
|
|
| Recruiting | 2 | 120 | RoW | Iron Isomaltoside 1000, Iron isomaltoside, Polysaccharide Iron Complex Pill, Intensity-modulated radiotherapy | Sun Yat-sen University | Nasopharyngeal Carcinoma, Iron-deficiency, Anemia | 05/24 | 05/26 | | |
| Not yet recruiting | 2 | 172 | RoW | Crisugabalin, Pregabalin | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Neuropathic Pain | 11/26 | 12/26 | | |
NCT05201859: Adjuvant Sintilimab Plus Capecitabine in Nasopharyngeal Carcinoma |
|
|
| Recruiting | 2 | 150 | RoW | Sintilimab, Anti-PD-1 Antibody, IBI308, Capecitabine | Sun Yat-sen University | Nasopharyngeal Carcinoma | 02/25 | 02/26 | | |
NCT06088004: Phase Ⅰ/Ⅱ Clinical Study to Evaluate ABO2011 in Advanced Solid Tumors |
|
|
| Recruiting | 1/2 | 218 | RoW | ABO2011 Injection, ABO2011, ABOD2011, Toripalimab | Suzhou Abogen Biosciences Co., Ltd., Abogen Biosciences (Shanghai) Co., Ltd | Solid Tumor, Adult | 12/26 | 12/27 | | |
NCT04850235: Nab-paclitaxel Based TPX Neoadjuvant Chemotherapy for NPC Patients: a Dose-escalation Study |
|
|
| Active, not recruiting | 1 | 36 | RoW | Nab paclitaxel | Sun Yat-sen University | Nasopharyngeal Cancer | 12/22 | 12/24 | | |
NCT05146050: Olfactory Change After Chemo-radiotherapy for Nasopharyngeal Carcinoma |
|
|
| Recruiting | N/A | 107 | RoW | | Sun Yat-sen University | Nasopharyngeal Carcinoma | 12/22 | 12/22 | | |
NCT05834712: Patients with Stage III-IVa Nasopharyngeal Carcinoma with or Without a Mobile Medical Platform Full-course Nutritional Intervention |
|
|
| Completed | N/A | 224 | RoW | mobile platform or not mobile platform | Sun Yat-sen University | Nasopharyngeal Carcinoma | 09/23 | 09/24 | | |
NCT06170021: Occurrence of Radiation-induced Otitis Media in Nasopharyngeal Carcinoma Patients After Intensity Modulated Radiotherapy |
|
|
| Recruiting | N/A | 215 | RoW | | Sun Yat-sen University | Nasopharyngeal Carcinoma | 12/25 | 12/25 | | |
NCT05183724: Ovarian Function of Nasopharyngeal Carcinoma Women Survivors |
|
|
| Not yet recruiting | N/A | 602 | RoW | | Sun Yat-sen University | Nasopharyngeal Carcinoma | 01/25 | 01/26 | | |
| feng, li xiao |
NCT05969054: Improvement Effect of Lacosamide and Levetiracetam on Cognitive in Alzheimer's Disease Patients With Epilepsy |
|
|
| Recruiting | 4 | 140 | RoW | Lacosamide 100 mg, Levetiracetam 250mg | Xiangya Hospital of Central South University | Alzheimer Disease 3, Epilepsy | 12/25 | 12/25 | | |
NCT05987397: Exploring the Preventive Effect of Mitochondrial Protective Agent Idebenone on Post-stroke Epilepsy |
|
|
| Recruiting | 4 | 2700 | RoW | idebenone 30 mg for 14 days, idebenone 30 mg for 3 months | Xiangya Hospital of Central South University | Post Stroke Epilepsy | 12/25 | 12/25 | | |
NCT05840341: Clinical Efficacy of QYHJ and Standard Chemotherapy in the Treatment of Advanced Pancreatic Cancer |
|
|
| Recruiting | 3 | 306 | RoW | QingyiHuaji optimized formula, standard chemotherapy | Fudan University | Pancreatic Neoplasms | 12/25 | 12/25 | | |
NCT06324266: Study on the Efficacy and Safety of Low-dose CTX as Maintenance Therapy for MM Unsuitable for Transplantation |
|
|
| Recruiting | 2/3 | 80 | RoW | Cyclophosphamide, CTX, Lenalidomide, Len | Jinling Hospital, China | Newly Diagnosed Multiple Myeloma | 12/25 | 12/25 | | |
| Completed | 2 | 82 | Europe, US, RoW | LUM-201, rhGH Norditropin® pen (34 µg/kg) | Lumos Pharma, Lumos Pharma | Growth Hormone Deficiency | 09/24 | 09/24 | | |
NCT05468502: Phase I/IIa Clinical Trial of Human Umbilical Cord Mesenchymal Stem Cell Injection in the Treatment of Idiopathic Pulmonary Fibrosis (IPF) |
|
|
| Recruiting | 1 | 18 | RoW | Human umbilical cord mesenchymal stem cell injection | Shanghai Life Science & Technology | Idiopathic Pulmonary Fibrosis | 08/24 | 08/25 | | |
SELECT-1, NCT04397432: Synergistic Effect of Elemene Plus TKIs Compared With TKIs in EGFR-mutated Advanced NSCLC：Retrospective Study |
|
|
| Active, not recruiting | N/A | 878 | RoW | | Tian Xie, LinkDoc Technology (Beijing) Co. Ltd. | Carcinoma, Non-Small-Cell Lung | 04/23 | 03/26 | | |
| Not yet recruiting | N/A | 176 | RoW | EECP, Sham-EECP | Sun Yat-sen University, First Affiliated Hospital, Sun Yat-Sen University, Third Affiliated Hospital, Sun Yat-Sen University, Second Affiliated Hospital of Shantou University Medical College, Second Affiliated Hospital of Guangzhou Medical University, Zhongshan People's Hospital, Guangdong, China, Jieyang People's Hospital | Mitral Regurgitation | 12/28 | 12/28 | | |
NCT04212494: Thrombus Aspiration in STEMI Patients With High Thrombus Burden |
|
|
| Recruiting | N/A | 3838 | RoW | Thrombus aspiration, PCI Alone | Guangdong Provincial People's Hospital, Zhongshan People's Hospital, Guangdong, China, Kaiping Central Hospital, The Second Affiliated Hospital of Shantou University Medical College, The Third Xiangya Hospital of Central South University, Sihui City People's Hospital, Shenzhen Baoan District Shiyan People's Hospital, People's Hospital of Nanxiong County, Yuebei People's Hospital, Weifang Medical University, Wuzhou Gongren Hospital, Dafeng Hospital of Chaoyang District in Shantou City, Shenzhen Baoan People's Hospital, Dongguan People's Hospital, Yangchun People's Hospital, Taishan People's Hospital, The Second People's Hospital of Foshan, Guangzhou Hospital of integrated Traditional and West Medicine, Guangning People's Hospital, Foshan Sanshui District People's Hospital, Qingyuan People's Hospital, Luhe County People's Hospital, People's Hospital of Xinjiang Uygur Autonomous Region, The Fourth People's Hospital of Chenzhou, People's Hospital of Dapu County, Shenzhen People's Hospital, Heyuan people's Hospital, Huaiji People's Hospital, People's Hospital of Yingde City, Qingyuan Hospital of Traditional Chinese Medicine Affiliated To Guangzhou University of Traditional Chinese Medicine, Zhongshan Hospital Of Traditional Chinese Medicine, The Third Affiliated Hospital of Guangzhou Medical University, Lianzhou People's Hospital, Lianping Xian Ren Ming Yi Yuan, Guangxi Zhuang Autonomous Region Nationalities Hospital, Liuzhou Municipal Liutie Central Hospital, Chen Zhou 3RD People's Hospital, Longgang District Central Hospital of Shenzhen, The Affiliated Shunde Hospital of Jinan University, Shenzhen Longhua District Central Hospital, Shantou Central Hospital, Tongxiang First People's Hospital, Bobai County People's Hospital, Guangxi, Meizhou Traditional Chinese Medicine Hospital, The Third Affiliated Hospital of Sun Yat-Sen University, Yuedong Hospital, Shenzhen Third People's Hospital, Yangjiang People's Hospital, Jiangmen Central Hospital, Eighth Affiliated Hospital, Sun Yat-sen University, The First People's Hospital of Kashgar Erea, First People's Hospital of Foshan, Zhaoqing Gaoyao People's Hospital, People's Hospital of Nanhai District, Foshan, The Second Affiliated Hospital of Dalian Medical University, Nanning Second People's Hospital, The Second People's Hospital of Nanhai District of Foshan, Shangyou People's Hospital | ST-segment Elevation Myocardial Infarction (STEMI) | 08/25 | 02/26 | | |
| Recruiting | N/A | 2000 | RoW | | Sun Yat-sen University, First Affiliated Hospital, Sun Yat-Sen University, Third Affiliated Hospital, Sun Yat-Sen University, Affiliated Hospital of Guangdong Medical University, Second Affiliated Hospital of Shantou University Medical College, Eighth Affiliated Hospital, Sun Yat-sen University, Zhongshan People's Hospital, Guangdong, China, Jieyang People's Hospital | Aortic Valve Disease | 03/28 | 03/28 | | |
| Ye, Qing Hai |
NCT04381143: ASPIrin in Reducing Events in Dialysis ( ASPIRED ) |
|
|
| Recruiting | 4 | 9000 | RoW | Aspirin 100 mg Oral Tablet, Matching Placebo | Guangdong Provincial People's Hospital, The George Institute | CKD (Chronic Kidney Disease) Stage 5D | 09/26 | 12/26 | | |
NCT05182463: Peginterferon Treatment Study for Inactive Chronic Hepatitis B Patients |
|
|
| Recruiting | 4 | 5000 | RoW | Peginterferon Alfa-2B, Nucleoside Analogs | Third Affiliated Hospital, Sun Yat-Sen University | Hepatitis B, Chronic | 12/26 | 11/29 | | |
